创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

LU Yi, HUANG Weizi, QI Jianping, WU Wei. Advances in the Research on Hybrid Nanocrystal and Its In Vivo Fate[J]. Progress in Pharmaceutical Sciences, 2020, 44(5): 342-350.
Citation: LU Yi, HUANG Weizi, QI Jianping, WU Wei. Advances in the Research on Hybrid Nanocrystal and Its In Vivo Fate[J]. Progress in Pharmaceutical Sciences, 2020, 44(5): 342-350.

Advances in the Research on Hybrid Nanocrystal and Its In Vivo Fate

  • Nanocrystals are promising in the delivery of poorly water-soluble drugs. However, information on the in vivo performance of nanocrystals is still not well understood. Physically embedded fluorophores in crystal lattice, i.e. the hybrid nanocrystals, enable bioimaging of nanocrystals. After a brief introduction to the up-to-date approaches to explore in vivo fates of nanocrystals, this article details the theoretical concepts as well as the techniques for the preparation and development of hybrid nanocrystals. Particular attention was paid to hybrid nanocrystals based on aggregation-caused quenching fluorescent probes as well as in vivo fates of nanocrystals via oral, intravenous and ocular routes obtained through this technique.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return